-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Prometheus Biosciences, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2020 to Q1 2023.
- Prometheus Biosciences, Inc. Nonoperating Income (Expense) for the quarter ending March 31, 2023 was $7.83M, a 25993% increase year-over-year.
- Prometheus Biosciences, Inc. Nonoperating Income (Expense) for the twelve months ending March 31, 2023 was $11.8M.
- Prometheus Biosciences, Inc. annual Nonoperating Income (Expense) for 2022 was $4.03M.
- Prometheus Biosciences, Inc. annual Nonoperating Income (Expense) for 2021 was -$2.39M, a 12.2% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)